Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 1/20 | 0.40 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.35 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 2/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.31 |
| ▸ | FLT3 | P36888 | 3/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21116470 | 0.94 | STS (0.41) | STSPRMT5WDR77CYP11B1CYP11B2 | |
| SCHEMBL23798849 | 0.93 | STS (0.40) | STSPRMT5WDR77CYP11B1CYP11B2 | |
| SCHEMBL21116274 | 0.90 | IMPDH2 (0.36) | ARIMPDH2CA1CA2 | |
| SCHEMBL19755261 | 0.89 | STS (0.36) | STSCYP11B1CYP11B2ARIMPDH2 | |
| SCHEMBL21116510 | 0.89 | CHEK1 (0.36) | IMPDH2 | |
| SCHEMBL22737033 | 0.88 | STS (0.37) | STSPRMT5WDR77CYP11B1CYP11B2 | |
| SCHEMBL20156132 | 0.88 | PTGER4 (0.35) | STSPRMT5WDR77CYP11B1CYP11B2 | |
| SCHEMBL21116873 | 0.88 | TRPA1 (0.41) | CYP11B1CYP11B2ARIMPDH2TRPA1 | |
| SCHEMBL19062218 | 0.88 | STS (0.43) | STSPRMT5WDR77CYP11B1CYP11B2 | |
| SCHEMBL21132052 | 0.87 | STS (0.39) | STSPRMT5WDR77CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NOX3, ORC3 | STS 1798/4885PRMT5 931/4885WDR77 3791/4885 |
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | OR10J3, ORC3, NOX3 | STS 1978/4885PRMT5 857/4885WDR77 3758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.